Furuzakura capsules 1mg, manufactured by Takeda Pharmaceutical, contain Fruquintinib. This kinase inhibitor is used for the treatment of metastatic colorectal cancer and has a YJ code of 4291088M1024, standardized as 1mg per capsule.
Furuzakura capsules 1mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
